Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · IEX Real-Time Price · USD
4.750
-0.100 (-2.06%)
Jul 19, 2024, 12:00 AM EDT - Market open
Intensity Therapeutics Employees
As of December 31, 2023, Intensity Therapeutics had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change
1
Growth
16.67%
Revenue / Employee
n/a
Profits / Employee
-$2,161,218
Market Cap
65.14M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7 | 1 | 16.67% |
Dec 31, 2021 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Prenetics Global | 324 |
Celularity | 225 |
HOOKIPA Pharma | 179 |
Vor Biopharma | 168 |
BioLineRx | 79 |
VSee Lab/iDoc Virtual Telehealth Solutions, Inc. | 40 |
Entera Bio | 18 |
Milestone Scientific | 17 |
INTS News
- 13 days ago - Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma - PRNewsWire
- 2 months ago - Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors - PRNewsWire
- 2 months ago - Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug Candidate - PRNewsWire
- 2 months ago - Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 - PRNewsWire
- 4 months ago - Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024 - PRNewsWire
- 5 months ago - Intensity Therapeutics to Present at the 2024 BIO CEO & Investor Conference - PRNewsWire